Filter
164
Filtered Results: 164
Text search:
antiepileptic
drugs
Featured
Recommendations
24
New Publications
31
Language
Document type
No document type
124
Guidelines
20
Studies & Reports
9
Manuals
7
Training Material
2
Fact sheets
2
Countries / Regions
India
10
Nepal
6
Africa
4
Latin America and the Carribbean
4
South Africa
4
Uganda
4
Ethiopia
4
Kenya
3
Rwanda
2
Malawi
2
Zimbabwe
2
Philippines
2
Global
2
Zambia
2
South Sudan
2
Eswatini/ Swaziland
2
Ukraine
1
Ghana
1
Sierra Leone
1
China
1
Syria
1
Nigeria
1
Afghanistan
1
Germany
1
Congo, Democratic Republic of
1
Middle East and North Africa
1
South–East Asia Region
1
Western and Central Europe
1
Paraguay
1
Argentina
1
Eastern Europe
1
Brazil
1
Russia
1
Bhutan
1
Botswana
1
Indonesia
1
Liberia
1
Authors & Publishers
Publication Years
Category
Drugs & Medical Equipment
17
Guidelines
12
Studies & Reports
9
Policies
6
Community Health
6
Paediatrics
4
Pediatrics
4
Policies & Guidelines HIV & TB
4
Clinical Guidelines
3
Women & Child Health
3
NTDs & Others
3
Water, Sanitation and Hygiene (WASH)
2
Mental Health
2
WASH
2
Communicable Diseases
2
Gynaecology & Obstetrics
2
Neonatal Care
2
Dental & Eye Care
1
Hepatitis
1
Emergency Health Kits
1
Pharmacy & Technology
1
Under-5 nutrition
1
Child Health
1
Diabetes
1
Taeniasis/ Cysticercosis
1
Neurology & Psychology
1
Dermatology
1
Cancer
1
Palliative Care
1
Cancer Treatment & Resources
1
Training Manuals
1
Child protection
1
Disabilities
1
Capacity Building
1
Humanitarian Crisis
1
Surgery & Anaesthesia
1
General Guidelines
1
Nutrition
1
Neurology & Psychology
1
Non-communicable Diseases
1
Disease Prevention & Control
1
Physiotherapy & Rehabilitation
1
Food Security & Nutrition
1
Toolboxes
Epilepsy
45
Neurological Disorders
35
Epilepsy
21
Children/Adolescents Mental Disorders
20
Training Supporting Material mhGAP
11
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
10
Mental Health GAP Action Programme
7
Essential Medicines & Devices Lists
6
Africa
5
others
5
Neurological disorders, Others
5
Psychosocial Support (MHPSS)
4
Rational use of Medicine
4
Substance Use Disorders & Addiction
4
Asia
4
War & Conflict
3
Children with Disabilities
3
Latin America
3
mhGAP Guides
3
Studies & Reports
3
Latin America
3
Mental Health Studies & Reports
3
Essential Medicines
3
Mental Disorders
3
Adults
2
Physical Disability
2
Policies & Programmes
2
Substance Use Disorders, Others
2
General Mental Health Guidelines
2
Africa
2
General Studies & Reports
2
Mental Health Guidelines
2
General Guidelines for Rational Use
2
Asia
2
Bipolar Affective Disorders
2
Self-harm & Suicide
2
IEC Material Neurological Disorders
2
Kenya
2
Training & Capacity Building
2
Best Practice Models
1
Statistics & Data
1
Mental Health
1
Mental Health
1
Health & Refugee
1
Public Health
1
Stress
1
Topics
1
Surveillance & Contact tracing
1
For Pregnant Women
1
Clinical Guidelines
1
Gender Aspects
1
Paediatrics
1
MHPSS – Psychosocial Support
1
Mental Health
1
Access & Strategy
1
Immunization Guidelines
1
Psychosocial Support
1
Logistics & Supply
1
Handbooks & Manuals
1
Triage
1
Pharmacy Practice
1
Traditional & Herbal Medicines
1
Humanitarian Crisis
1
Pharmacovigilance
1
Reports & Studies
1
Clinical Aspects & Diagnosis
1
General
1
Mental disorders, others
1
Modules
1
Germany
1
IEC Materials Children
1
Assessment
1
Zika Prevention & Control
1
Anxiety Disorders
1
Psychosocial Support
1
MHPSS Guidelines
1
Community Based Rehabilitation (CBR)
1
Guidelines CBR
1
Psychosocial Support
1
Preparedness & Prevention
1
3rd edition
Q9. In adults and children with convulsive epilepsy in remission, when should treatment be discontinued?
Q 7: For adults and children with convulsive epilepsy, which standard antiepileptic drugs (phenobarbital, phenytoin, carbamazepine, valproic acid) when compared to placebo/a comparator produce benefits/harm in the specified outcomes?
SCOPING QUESTION: In adults with acute convulsive seizures, where intravenous access is available, which first-line anti- epileptic medication should be used to abort seizures when compared to comparator?
Q12: Should the treatment be similar in individuals with intellectual disability and epilepsy compared to people with epilepsy only?
SCOPING QUESTION: For adults and children with medication-resistant convulsive epilepsy, which anti-epileptic medications produce benefits and/or harm in the specified outcomes when compared to a placebo or a comparator?
6th edition, The NLEM 2021 contains 398 drugs molecules in different therapeutic categories.
This is the fifteenth edition of the lecture notes. They were first published in 1987 as a summary of the material used in the biannual epilepsy teaching weekend organised under the auspices of the UK Chapter of the International League against Epilepsy.
(Lecture series consist of a total of 59 cha...
Second Edition, 2012
Q 10: In adults and children with epilepsy, which psychological interventions used as adjunctive therapies with antiepileptic drugs when compared to placebo/comparator produce benefits/harm in specified outcomes?
Q8. Should Anti-Epileptic Drug (AED) treatment be started after first unprovoked seizure in non-specialist health settings?
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
[Updated 2015]
Scoping Question: In adults with acute convulsive seizures in first-level care or in the community (when no IV access is available), which antiepileptic medications produce benefits and/or harm when compared to comparator?
SCOPING QUESTION: In adults with established status epilepticus (i.e., seizures persisting after the first-line treatment with benzodiazepines [or benzodiazepines-resistant status epilepticus]), which anti-epileptic medications are associated with cessation of seizures and reduced adverse effects)?
...
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Uptsate 2017
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i...
Low- and middle-income countries (LMICs) experience a high disease burden for epilepsy, a chronic neurological condition.The authors evaluate the cost-effectiveness of community health workers (CHWs) to improve adherence to medication for epilepsy in South Africa. They found that utilizing CHWs to i...
